Elicio Therapeutics, Inc. (ELTX)
10.65
-0.01
(-0.09%)
USD |
NASDAQ |
Apr 02, 16:00
10.54
-0.11
(-1.03%)
After-Hours: 20:00
Elicio Therapeutics EPS Diluted (Quarterly) : -0.4336 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Aura Biosciences, Inc. | -0.4019 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.718M |
| Total Expenses (Quarterly) | 7.718M |
| Enterprise Value | 191.87M |
| Earnings Yield | -24.32% |
| Normalized Earnings Yield | -23.45 |